CTI BioPharma Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
CTI BioPharma (CTIC) Misses Q3 EPS by 7c
November 5, 2015 4:14 PM ESTCTI BioPharma (NASDAQ: CTIC) reported Q3 EPS of ($0.19), $0.07 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $1 million versus the consensus estimate of $16.3 million.
For earnings history and earnings-related data on CTI BioPharma (CTIC) click here.
... More


